Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial

Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial

Abstract Introduction Soluble urokinase plasminogen activator receptor (suPAR) is a prognostic and nonspecific biomarker associated with short-term mortality in emergency department (ED) patients. Therefore, the blood level of suPAR might be usable for identification of patients at high- and low ris...

Full description

Bibliographic Details
Main Authors: Martin Schultz, Line J. H. Rasmussen, Thomas Kallemose, Erik Kjøller, Morten N. Lind, Lisbet Ravn, Theis Lange, Lars Køber, Lars S. Rasmussen, Jesper Eugen-Olsen, Kasper Iversen
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Subjects:
Emergency department
Triage
Risk stratification
Prognostic biomarkers
suPAR
Online Access:http://link.springer.com/article/10.1186/s13049-019-0621-7

Internet

http://link.springer.com/article/10.1186/s13049-019-0621-7

Similar Items